Aspen Pharmacare (OTCMKTS:APNHY – Get Free Report) shares gapped down prior to trading on Thursday . The stock had previously closed at $9.41, but opened at $9.00. Aspen Pharmacare shares last traded at $9.00, with a volume of 1,160 shares trading hands.
Aspen Pharmacare Price Performance
The business has a 50-day moving average of $8.77 and a 200 day moving average of $7.94. The company has a debt-to-equity ratio of 0.36, a current ratio of 3.64 and a quick ratio of 2.66.
About Aspen Pharmacare
Aspen Pharmacare Holdings Limited is a multinational pharmaceutical company headquartered in Durban, South Africa. Founded in 1997 by Stephen Saad and Gus Attridge, Aspen has grown from a regional generic drug producer into a global specialist in branded and generic medicines. The company is publicly traded on the Johannesburg Stock Exchange and its American depositary receipts trade over‐the‐counter under the symbol APNHY.
Aspen’s core business encompasses the development, manufacture and distribution of a broad portfolio of injectable and oral pharmaceutical products.
Featured Stories
- Five stocks we like better than Aspen Pharmacare
- Dollar Tree’s Turnaround Is Starting to Take Root
- Why Levi’s Digital Strategy Is Paying Off in a Big Way
- Constellation Brands: Beer Growth and Buybacks Mask Stock’s Slump
- Lockheed Martin Secures the Ultimate Defense Moat
Receive News & Ratings for Aspen Pharmacare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aspen Pharmacare and related companies with MarketBeat.com's FREE daily email newsletter.
